NBIX

NEUROCRINE BIOSCIENCES INC

Healthcare | Large Cap

$2.13

EPS Forecast

$1,067

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

$2.13

Revenue Forecast:

$1,067

EPS Surprise Forecast:

$0.184

Revenue Surprise Forecast:

$26

Post-release price volatility - High

Post-release Overnight Move:

±7.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

82%

Probability of beating revenue consensus:

86%

Probability of beating both EPS & revs consensus:

74%

Probability of missing both EPS & revs consensus:

6%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

0.43

Earnings volatility

EPS standard deviation:

$0.47

Revenue standard deviation:

$44

As % of share price:

0.33% VERY HIGH

As % of market cap:

0.30% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$2.78

Revenue 95th %ile:

$1,128

EPS 75th %ile:

$2.31

Revenue 75th %ile:

$1,083

EPS 25th %ile:

$2.01

Revenue 25th %ile:

$1,052

EPS 5th %ile:

$1.66

Revenue 5th %ile:

$1,016

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

49% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$12

Bid-ask per Share:

$0.17